Henk M. Lokhorst
Amsterdam UMC Location Vrije Universiteit Amsterdam(NL)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, Immunotherapy and Immune Responses, CAR-T cell therapy research
Most-Cited Works
- → Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group(2015)2,132 cited
- → Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma(2015)1,106 cited
- → Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors(2010)1,004 cited
- → Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma(2016)900 cited
- → Bortezomib Induction and Maintenance Treatment in Patients With Newly Diagnosed Multiple Myeloma: Results of the Randomized Phase III HOVON-65/ GMMG-HD4 Trial(2012)821 cited
- → Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myeloma(2016)403 cited